5-azacytidine treatment results in myelodysplastic syndrome

被引：0
|
作者：
Bakanay, S. M. [1 ]
Karakilic, E. [1 ]
Civriz-Bozdag, S. [1 ]
Arat, M. [1 ]
Ozcan, M. [1 ]
Gurman, G. [1 ]
Ilhan, O. [1 ]
Beksac, M. [1 ]
Konuk, N. [1 ]
Arslan, O. [1 ]
机构：
[1] Ankara Univ, Sch Med, TR-06100 Ankara, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18003
引用
收藏
页数：2
相关论文
共 50 条
  • [21] EFFECTS OF TREATMENT WITH 5-AZACYTIDINE ON THE INVIVO AND INVITRO HEMATOPOIESIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    SILVERMAN, LR
    HOLLAND, JF
    WEINBERG, RS
    ALTER, BP
    DAVIS, RB
    ELLISON, RR
    DEMAKOS, EP
    CORNELL, CJ
    CAREY, RW
    SCHIFFER, C
    ILL, EF
    MCINTYRE, OR
    LEUKEMIA, 1993, 7 : 21 - 29
  • [22] Predonor lymphocyte infusion treatment with 5-azacytidine as salvage treatment in relapsed acute myeloid leukaemia secondary to myelodysplastic syndrome
    Villela, Luis
    Anders, Viki
    Bolanos-Meade, Javier
    ANTI-CANCER DRUGS, 2010, 21 (04) : 469 - 469
  • [23] Combination of 5-azacytidine and thalidomide for the treatment of myelodysplastic syndromes and acute myeloid leukemia
    Raza, Azral
    Mehdi, Munaza
    Mumtaz, Muhammad
    Ali, Fahad
    Lascher, Steven
    Galili, Naomi
    CANCER, 2008, 113 (07) : 1596 - 1604
  • [24] The Hedgehog pathway as targetable vulnerability with 5-azacytidine in myelodysplastic syndrome and acute myeloid leukemia
    Tibes, Raoul
    Al-Kali, Aref
    Oliver, Gavin R.
    Delman, Devora H.
    Hansen, Nanna
    Bhagavatula, Keerthi
    Mohan, Jayaram
    Rakhshan, Fariborz
    Wood, Thomas
    Foran, James M.
    Mesa, Ruben A.
    Bogenberger, James M.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2015, 8
  • [25] The autoimmune manifestations associated with myelodysplastic syndrome respond to 5-azacytidine: a report on three cases
    Pilorge, Sylvain
    Doleris, Luc Moulonguet
    Dreyfus, Francois
    Park, Sophie
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 (05) : 664 - 665
  • [26] Therapeutic effect of 5-azacytidine on myelodysplastic syndrome is augmented through demethylation of cytidine deaminase
    Murakami, Yuichi
    Kawahara, Akihiko
    Watari, Kosuke
    Akiba, Jun
    Kuwano, Michihiko
    Ono, Mayumi
    CANCER SCIENCE, 2018, 109 : 249 - 249
  • [27] The Hedgehog pathway as targetable vulnerability with 5-azacytidine in myelodysplastic syndrome and acute myeloid leukemia
    Raoul Tibes
    Aref Al-Kali
    Gavin R Oliver
    Devora H Delman
    Nanna Hansen
    Keerthi Bhagavatula
    Jayaram Mohan
    Fariborz Rakhshan
    Thomas Wood
    James M. Foran
    Ruben A. Mesa
    James M. Bogenberger
    Journal of Hematology & Oncology, 8
  • [28] Antiretroviral activity of 5-azacytidine during treatment of a HTLV-1 positive myelodysplastic syndrome with autoimmune manifestations
    Diamantopoulos, Panagiotis T.
    Michael, Maria
    Benopoulou, Olga
    Bazanis, Efthymia
    Tzeletas, George
    Meletis, John
    Vayopoulos, George
    Viniou, Nora-Athina
    VIROLOGY JOURNAL, 2012, 9
  • [29] Treatment of relapsed myelodysplastic syndrome following double umbilical cord blood transplantation with interferon alpha and 5-azacytidine
    Samuelson, Clare
    Dalley, Christopher
    Ezaydi, Yousef
    Collins, Noel
    Snowden, John A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 (05) : 602 - 604
  • [30] Antiretroviral activity of 5-azacytidine during treatment of a HTLV-1 positive myelodysplastic syndrome with autoimmune manifestations
    Panagiotis T Diamantopoulos
    Maria Michael
    Olga Benopoulou
    Efthymia Bazanis
    George Tzeletas
    John Meletis
    George Vayopoulos
    Nora-Athina Viniou
    Virology Journal, 9
12345